Format

Send to

Choose Destination
See comment in PubMed Commons below
Vnitr Lek. 2012 Jan;58(1):38-43.

[Light chain deposition disease].

[Article in Czech]

Author information

1
III. Interní Nefrologická, Revmatologická a Endokrinologiká Klinika Lékarské Fakulty UP a Olomouc, Prednosta prof. MUDr. Vlastimil Scudla, CSc. vlastimil.scudla@fnol.cz

Abstract

The aim of the study is to put forward the recent knowledge about a relatively rare clinical condition caused by the deposition of immunoglobulin light chains κ or λ into the parenchyme of kidneys and other vital organs, leading to a progressive loss of their function with terminal organ failure. The paper focuses on the etiopathogenesis of light chain deposition disease, and the differentiation of idiopatic form of the disease from multiple myeloma associated conditions and other B lymphoproliferative disorders. We concentrate on the issue of clinical manifestation, contemporary diagnostic possibilities and differential diagnosis of the disease. Finally, we summarize recent therapeutic approaches using chemo-immunotherapy (bortezomib) and high-dosed chemotherapy with support of autologous peripheral stem cell transplantation that lead to a substantial improvement of the prognosis of this prognostically unfavorable disorder.

PMID:
22448699
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for proLekare.cz
    Loading ...
    Support Center